| 1 |
31568878 | Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy. | 2019 Dec |
1 |
| 2 |
24039769 | A cell-permeable fusion protein based on Clostridium botulinum C2 toxin for delivery of p53 tumorsuppressor into cancer cells. | 2013 |
1 |
| 3 |
21360640 | Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration. | 2011 Feb |
3 |
| 4 |
19845689 | Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling. | 2010 Feb |
1 |
| 5 |
11866879 | Synergism between heparin and adriamycin on cell proliferation and apoptosis in human nasopharyngeal carcinoma CNE2 cells. | 2002 Feb |
1 |
| 6 |
11296226 | p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. | 2001 Apr 17 |
2 |
| 7 |
10432310 | Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. | 1999 Aug 15 |
4 |
| 8 |
2052362 | Association of casein kinase II with immunopurified p53. | 1991 May |
1 |